RetractedArticleDisease markers2022

Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma.

Menglong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.